Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chondrocalcinosis after parathyroidectomy.

J S Glass, R Grahame

    Annals of the Rheumatic Diseases
    |December 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Chondrocalcinosis affects 40% of primary hyperparathyroidism patients post-parathyroidectomy. Surgery did not improve joint symptoms or chondrocalcinosis, with some cases worsening or appearing after the operation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The association between Ehlers-Danlos syndrome-hypermobility type and gastrointestinal symptoms in university students: a cross-sectional study.

    Neurogastroenterology and motility·2016
    Same author

    Ehlers-Danlos syndrome.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2016
    Same author

    Functional gastrointestinal disorders are associated with the joint hypermobility syndrome in secondary care: a case-control study.

    Neurogastroenterology and motility·2015
    Same author

    Lower urinary tract symptoms in women with benign joint hypermobility syndrome: a case-control study.

    International urogynecology journal·2013
    Same author

    Prolapse and sexual function in women with benign joint hypermobility syndrome.

    BJOG : an international journal of obstetrics and gynaecology·2012
    Same author

    Thiopurinol: comparative enzyme inhibition and protein binding studies with allopurinol, oxipurinol and 6-mercaptopurine.

    British journal of clinical pharmacology·2012
    Same journal

    Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project.

    Annals of the rheumatic diseases·2026
    Same journal

    Commentary on 'Assessing the performance of AI chatbots in answering patients common questions about low back pain'.

    Annals of the rheumatic diseases·2026
    Same journal

    Response to Correspondence on 'Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial'.

    Annals of the rheumatic diseases·2026
    Same journal

    Correspondence on 'Safety and immunogenicity of the recombinant zoster vaccine in patients with rheumatoid arthritis using abatacept: a pilot multicentre, double-blind, randomised controlled trial' by Hawkins et al.

    Annals of the rheumatic diseases·2026
    Same journal

    Response to correspondence on 'Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis' by Kaundal et al.

    Annals of the rheumatic diseases·2026
    Same journal

    Correspondence on 'Gain of function NOTCH4 variants disrupt angiogenesis in systemic sclerosis' by Kaundal et al.

    Annals of the rheumatic diseases·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Rheumatology
    • Surgical Oncology

    Background:

    • Primary hyperparathyroidism is a condition characterized by excessive parathyroid hormone production.
    • Parathyroidectomy is the surgical removal of parathyroid glands, often indicated for primary hyperparathyroidism.
    • Chondrocalcinosis, or calcium pyrophosphate dihydrate crystal deposition disease, is associated with metabolic disorders.

    Observation:

    • This retrospective study analyzed 57 patients with primary hyperparathyroidism who underwent parathyroidectomy.
    • The incidence of chondrocalcinosis was assessed in these patients.
    • Clinical and radiological data were reviewed to evaluate changes post-surgery.

    Findings:

    • The overall incidence of chondrocalcinosis among patients with primary hyperparathyroidism was 40%.

    Related Experiment Videos

  • Parathyroidectomy did not lead to regression of joint symptoms or chondrocalcinosis.
  • In some patients, chondrocalcinosis worsened post-operatively, and in a few, it appeared de novo after surgery.

    • Implications:

    • Parathyroidectomy may not resolve or could potentially exacerbate chondrocalcinosis in patients with primary hyperparathyroidism.
    • Further research is needed to understand the relationship between parathyroid hormone levels, parathyroidectomy, and chondrocalcinosis development.
    • Consideration of chondrocalcinosis screening and management in primary hyperparathyroidism patients is warranted.